Molly Chiaramonte, Ph.D is a Senior Vice President at Royalty Pharma, where she has led numerous diligence efforts as part of the Research & Investments team since January of 2008. Royalty Pharma is the industry leader in acquiring royalty interests in marketed and late-stage biopharmaceutical products, with a portfolio that includes royalty interests in over 40 approved products valued at over $16 billion.
Prior to joining Royalty Pharma, Molly worked as a biotechnology equity research associate at Jefferies & Company from 2006 to 2008. From 2002 to 2006, she was a post-doctoral fellow in the Department of Biochemistry and Molecular Genetics at the University of Colorado Health Sciences Center. Molly earned a BA in mathematics, summa cum laude, from Providence College; an MA in mathematics from the University of Colorado; and a PhD in chemistry (Biochemistry Program) from the University of Colorado.